These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28166391)

  • 21. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives.
    Pasmatzi E; Papadionysiou C; Monastirli A; Badavanis G; Tsambaos D
    An Bras Dermatol; 2019 Jul; 94(3):348-354. PubMed ID: 31365668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
    Iurisci I; Cumashi A; Sherman AA; Tsvetkov YE; Tinari N; Piccolo E; D'Egidio M; Adamo V; Natoli C; Rabinovich GA; Iacobelli S; Nifantiev NE;
    Anticancer Res; 2009 Jan; 29(1):403-10. PubMed ID: 19331179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair.
    Gendronneau G; Sanii S; Dang T; Deshayes F; Delacour D; Pichard E; Advedissian T; Sidhu SS; Viguier M; Magnaldo T; Poirier F
    PLoS One; 2015; 10(3):e0119031. PubMed ID: 25741714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
    Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
    Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examination of the role of galectins and galectin inhibitors in endothelial cell biology.
    Schulkens IA; Kleibeuker EA; Castricum KC; Griffioen AW; Thijssen VL
    Methods Mol Biol; 2015; 1207():285-91. PubMed ID: 25253147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin expression in healing wounded skin treated with low-temperature plasma: Comparison with treatment by electronical coagulation.
    Akimoto Y; Ikehara S; Yamaguchi T; Kim J; Kawakami H; Shimizu N; Hori M; Sakakita H; Ikehara Y
    Arch Biochem Biophys; 2016 Sep; 605():86-94. PubMed ID: 26827730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.
    van Beijnum JR; Thijssen VL; Läppchen T; Wong TJ; Verel I; Engbersen M; Schulkens IA; Rossin R; Grüll H; Griffioen AW; Nowak-Sliwinska P
    Int J Cancer; 2016 Aug; 139(4):824-35. PubMed ID: 27062254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present).
    Sethi A; Sanam S; Alvala R; Alvala M
    Expert Opin Ther Pat; 2021 Aug; 31(8):709-721. PubMed ID: 33749494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galectin-7 as a potential mediator of corneal epithelial cell migration.
    Cao Z; Said N; Wu HK; Kuwabara I; Liu FT; Panjwani N
    Arch Ophthalmol; 2003 Jan; 121(1):82-6. PubMed ID: 12523890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
    Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
    Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of stable and selective inhibitors of human galectins-1 and -3.
    Giguère D; Bonin MA; Cloutier P; Patnam R; St-Pierre C; Sato S; Roy R
    Bioorg Med Chem; 2008 Aug; 16(16):7811-23. PubMed ID: 18674915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3.
    Giguère D; Sato S; St-Pierre C; Sirois S; Roy R
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1668-72. PubMed ID: 16403629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
    Tejler J; Skogman F; Leffler H; Nilsson UJ
    Carbohydr Res; 2007 Sep; 342(12-13):1869-75. PubMed ID: 17407769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3.
    Giguère D; Patnam R; Bellefleur MA; St-Pierre C; Sato S; Roy R
    Chem Commun (Camb); 2006 Jun; (22):2379-81. PubMed ID: 16733586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-7 in the control of epidermal homeostasis after injury.
    Gendronneau G; Sidhu SS; Delacour D; Dang T; Calonne C; Houzelstein D; Magnaldo T; Poirier F
    Mol Biol Cell; 2008 Dec; 19(12):5541-9. PubMed ID: 18829868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Tocopherol promotes HaCaT keratinocyte wound repair through the regulation of polarity proteins leading to the polarized cell migration.
    Horikoshi Y; Kamizaki K; Hanaki T; Morimoto M; Kitagawa Y; Nakaso K; Kusumoto C; Matsura T
    Biofactors; 2018 Mar; 44(2):180-191. PubMed ID: 29399897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.
    Bartolazzi A; Sciacchitano S; D'Alessandria C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.
    Wolfenden M; Cousin J; Nangia-Makker P; Raz A; Cloninger M
    Molecules; 2015 Apr; 20(4):7059-96. PubMed ID: 25903363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology.
    Sewgobind NV; Albers S; Pieters RJ
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.